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Summary
Recently extravasated metastatic cancer cells employ the Rif/mDia2 actin-nucleating/
polymerizing machinery in order to extend integrin β1-containing, filopodium-like protrusions
(FLPs), which enable them to interact productively with the surrounding extracellular matrix; this
process governs the initial proliferation of these cancer cells. Here we identify the signaling
pathway governing FLP lifetime, which involves integrin-linked kinase (ILK) and β-parvin, two
integrin:actin-bridging proteins, that block cofilin-mediated actin-filament severing. Importantly,
the combined actions of Rif/mDia2 and ILK/β-parvin/cofilin pathways on FLPs are required not
only for metastatic outgrowth but also for primary tumor formation following experimental
implantation. This provides one mechanistic explanation for how the epithelial-mesenchymal
transition (EMT) program imparts tumor-initiating powers to carcinoma cells, since it enhances
FLP formation through the activation of ILK/β-parvin/cofilin pathway.
Introduction
The great majority of disseminated cancer cells fail to survive and proliferate after landing
in a foreign tissue (Chambers et al., 2002). This explains why only a small minority of
disseminated cancer cells succeeds, via the process of colonization, in generating the
macroscopic metastases that are responsible for more than 90% of cancer-associated deaths
(Fidler, 2003). This highlights the need to elucidate the mechanisms that allow metastasized
cells to survive and proliferate after settling in the parenchyma of foreign tissues.
We and others previously studied a set of three mouse mammary carcinoma cell lines –
D2.0R, D2.1 and D2A1 (hereafter collectively referred to as D2 cells) – with differing
metastatic potentials (Barkan et al., 2008; Shibue and Weinberg, 2009). Thus, after being
introduced into mice via the tail vein, these three cell populations extravasate into the lung
parenchyma with equal efficiency and exhibit comparable rates of initial survival; however,
while the colonization-competent D2A1 cells subsequently proliferate rapidly, the
colonization-deficient D2.0R and D2.1 cells fail to do so (see Figure S1A). Hence, these
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three D2 cell populations provide a model system to study the mechanisms governing the
proliferation of recently extravasated cancer cells in the lung parenchyma.
These studies led us to discover that focal adhesion kinase (FAK) signaling governs the
post-extravasation proliferation of the aggressive D2A1 cells in the lungs, doing so by
controlling the activity of the extracellular-signal regulated kinases (ERKs) (Shibue and
Weinberg, 2009; Shibue et al., 2012). FAK activation in these D2A1 cells appeared to
depend, in turn, on the interactions of these cells with components of the extracellular matrix
(ECM) in the lung parenchyma, which are mediated specifically by the formation of
elongated, integrin β1-containing adhesion plaques. We found that the development of such
plaques require the prior assembly of integrin β1-containing, filopodium-like protrusions
(FLPs) – actin-rich protrusions morphologically resembling filopodia formed by cells
growing in monolayer culture. In contrast, the slowly-proliferating D2.0R and D2.1 cells
develop very few FLPs and elongated adhesion plaques in the lung parenchyma and display
low levels of FAK and ERK activation (Shibue et al., 2012; Figure S1A).
By testing various breast cancer cell lines that exhibit differing metastatic powers in mice,
we also found that a diverse array of colonization-competent cells assemble such FLPs in far
greater numbers than do their colonization-deficient counterparts (Shibue et al., 2012). This
suggested that the ability to extend abundant FLPs critically determines the competence of
these breast cancer cells to colonize foreign tissues. In the present study, we undertook to
identify the key regulators of FLP formation with anticipation that these regulators also
serve as molecular determinants of colonization competence.
Results
Differing expression levels of β-parvin in colonization-competent and -deficient cells
In an attempt to elucidate the mechanism(s) governing FLP formation, we exploited a three-
dimensional (3D) culture model, termed “Matrigel on-top” (MoT), in which cells are plated
above a layer of 100% Matrigel and then covered with culture medium containing 2%
Matrigel (Debnath et al., 2003). When propagated in this MoT model, the aggressive D2A1
cells displayed abundant FLPs, while the nonaggressive D2.0R and D2.1 cells failed to do
so; this mirrored the in vivo behaviors of these various cell types in the lung parenchyma
(Shibue et al., 2012; Figures S1A, S1B).
In order to identify the mechanistic basis of differing FLP abundance observed in the MoT
cultures, we tested the kinetics of FLP assembly and disassembly by time-lapse imaging. We
found that the rate of de novo FLP formation was not noticeably different among these three
D2 cell types (Figure 1A). In contrast, they exhibited a profound difference in the lifetime of
FLPs: more than 60% of FLPs observed in the aggressive D2A1 cells persisted for more
than 6 hours, while the majority (> 75%) of FLPs formed in the nonaggressive D2.0R and
D2.1 cells persisted less than 90 minutes (Figure 1A, Movies S1–S3). This indicated that the
difference in FLP abundance between these cell types could be attributed largely to the
differing lifetimes of FLPs.
We proceeded to identify the molecular machinery governing FLP lifetime. In previous
work, we found that the FLPs formed by the aggressive D2A1 cells in MoT culture
displayed the β1 subunit of integrins along the lengths of their shafts (Shibue et al., 2012).
We also noted that others had demonstrated the critical role of integrin-ECM ligation in
controlling local actin dynamics (Geiger et al., 2001). Together, these observations led us to
speculate that the engagement of β1-subunit-containing integrins with their ECM ligands
along the lengths of FLP shafts governs the persistence of actin fibers that structurally
support FLPs, thereby controlling FLP lifetime. Consistent with this speculation, the
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knockdown of integrin β1 expression in the D2A1 cells significantly reduced the lifetime, as
well as the steady-state numbers, of FLPs formed by these cells (Figure S1C). In contrast,
the knockdown of integrin β1 expression in the poorly-FLPdisplaying D2.0R and D2.1 cells
did not noticeably reduce either the abundance or lifetime of FLPs (Figure S1D).
Nonetheless, the short-lived FLPs that are naturally formed by these two indolent cell types,
like those extended by the aggressive D2A1 cells, harbored integrin β1 along their shafts, as
demonstrated by use of an active-conformation specific antibody 9EG7 (Lenter et al., 1993;
Figure S1E). We concluded that integrin β1 was actively involved in the adhesions to ECM
occurring along the shafts of FLPs in all the three types of D2 cells, regardless of the
persistence time of their FLPs. It appeared, therefore, that integrin β1-mediated adhesions
contributed critically to the prolonged lifetime of FLPs in the aggressive D2A1 cells, doing
so by increasing the persistence of actin filaments that formed the core of these protrusions,
whereas formation of these adhesions did not appear to affect the stability of the FLPs in the
indolent D2.0R and D2.1 cells.
Based on this thinking, we examined the mechanisms connecting integrin β1-mediated
adhesions with the actin fibers that structurally support FLPs. In particular, we addressed the
roles of integrin:actin-linking proteins, which are thought to govern the coordination
between the integrin-mediated adhesions and the control of actin organization in the vicinity
of these adhesions (Geiger et al., 2001). To begin, we measured the abundance of mRNAs
encoding 23 known linker proteins. Among these, the mRNA encoding β-parvin stood out,
since its levels were approximately 100-fold higher in the aggressive D2A1 cells than in the
other two indolent D2 cell types. In contrast, none of the other 22 mRNAs surveyed
exhibited more than a 2.2-fold difference in expression levels in the D2A1 cells relative to
the mean expression levels in the indolent D2.0R and D2.1 cells (Figure 1B).
As expected from mRNA expression, the expression of β-parvin protein could be detected
by immunoblotting only in the aggressive D2A1 cells (Figure 1C). Moreover, the
knockdown of β-parvin expression by 87–94% in the D2A1 cells caused a 51–56% decrease
in FLP abundance as well as a significant reduction of FLP lifetime (Figures 1D, 1E, S1F,
Movies S4, S5). In addition, the knockdown of the expression of integrin-linked kinase
(ILK), an essential linker between β-parvin and integrin β chains (Yamaji et al., 2001; Figure
2A), also reduced the number of FLPs in the D2A1 cells (Figure 1D). Conversely, ectopic β-
parvin expression in the more indolent D2.0R and D2.1 cells extended FLP lifetime and
increased the steady-state number of these protrusions, an effect that could be blunted by
concomitant ILK knockdown (Figures S1F–H, Movies S6, S7). Hence, the differences in the
lifetime and thus abundance of FLPs observed in the various D2 cell types were attributable,
at least in part, to the differing expression levels of β-parvin, which appeared to control FLP
lifetime in an ILK-dependent manner.
βPIX/Cdc42/PAK axis as an effector of ILK/β-parvin in controlling FLP formation
Given the key role played by β-parvin in the regulation of FLPs, we sought to uncover the
role of other proteins beyond ILK that might collaborate with β-parvin in this process. In
fact, in addition to serving as a physical link between integrins and the actin cytoskeleton, β-
parvin is known to play a regulatory role in the cytoskeleton by interacting with αPIX and
βPIX (PAK-interacting exchange factors) (Rosenberger et al., 2003). Both PIX proteins
recruit and then activate Cdc42 and Rac1 GTPases, which in turn proceed to activate the
Group I class of p21-activated kinases (PAKs), i.e., PAK1-3, thereby regulating cytoskeletal
organization (Figure 2A; Bokoch, 2003).
We therefore determined whether PIX/Cdc42(Rac)/PAK signaling contributes to the β-
parvin-dependent process of FLP regulation. Immunoprecipitation analysis revealed that β-
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parvin expressed in the aggressive D2A1 cells interacted physically with βPIX, the only PIX
isoform expressed at a detectable level in these cells (Figures 2B, S2F). Moreover, the
knockdown of βPIX expression (by 98–99%) resulted in a 46–66% decrease in the number
of FLPs formed by the MoT-cultured D2A1 cells (Figures 2C, S2A), indicating that β-parvin
cooperates with βPIX in regulating FLP abundance.
We proceeded to examine the role of β-parvin in driving the signaling events downstream of
βPIX, namely, the sequential activation of Cdc42 (Rac1) and PAK1-3. The knockdown of β-
parvin expression in the D2A1 cells grown in MoT culture reduced the levels of GTP-
bound, active Cdc42 and Rac1 by 70–88% and 57–78%, respectively (Figures 2D, S2B).
This was accompanied by the reduced phosphorylation of PAK1 at residues critical to its
kinase activity – threonine 423 (T423) within its catalytic domain as well as serines 199 and
204 (S199/204) within its autoinhibitory domain (Figure 2E). Conversely, β-parvin
overexpression in the MoT-cultured, otherwise-indolent D2.0R and D2.1 cells elevated the
levels of active Cdc42 and Rac1 and augmented phosphorylation of PAK1 on T423 and
S199/204 (Figures 2D, 2E, S2B). Hence, in these D2 carcinoma cell types, β-parvin
expression was both necessary and sufficient for activating Cdc42, Rac1 and PAKs when
these cells were growing in MoT cultures.
We also compared the roles of Cdc42 and Rac1 as downstream effectors of the β-parvin/
βPIX complex and found that Cdc42 knockdown reduced both PAK1 phosphorylation and
FLP abundance far more efficiently than did Rac1 knockdown (Figures 2E, S2C, S2D;
Shibue et al., 2012). This indicated that Cdc42, rather than Rac1, serves as a key
intermediary in the β-parvin/βPIX-dependent PAK activation.
Finally, we tested the involvement of PAKs in FLP regulation. The inhibition of PAK
activity by overexpressing a dominant-negative PAK1-AID fragment, which inhibits all the
three of PAK1-3 (Zhao et al., 1998), resulted in a 47% reduction in the number of FLPs
formed by the D2A1 cells in MoT culture (Figure 3A). Conversely, overexpression of a
constitutively active PAK1 mutant (PAK1 L107F) in the D2.0R and D2.1 cells increased the
number of FLPs by 3.2- and 3.0-fold, respectively (Figure 3A). Together, these observations
demonstrated the critical role of the ILK/β-parvin/βPIX/Cdc42/PAK signaling axis in
supporting abundant FLP display (see Figure 3B).
LIMK/cofilin axis as a downstream mediator of the effect of PAKs on FLPs
The work described above did not reveal how PAKs control FLP abundance. However, we
noted that earlier studies had implicated the presence of multiple effector pathways
contributing to the PAK-dependent control of cytoskeletal organization (Bokoch, 2003;
Figure 3B). Thus, PAKs activate LIM domain kinases (LIMKs), which in turn inactivate the
ADF/cofilin family of proteins (i.e., ADF, cofilin1 and cofilin2; hereafter referred to
collectively as cofilin), the central regulators of actin filament severing. Independent of this,
PAKs also impair actomyosin contractility by inactivating myosin light-chain kinase
(MLCK), thereby reducing the phosphorylation level of the regulatory myosin light chain
(rMLC) (see Figure 2A).
We undertook to specify the role(s) of PAKs in FLP regulation. In the MoT-cultured,
aggressive D2A1 cells, the inhibition of PAK activity, achieved either by β-parvin
knockdown or PAK1-AID overexpression, impaired the phosphorylation of cofilin1 on
serine 3 (S3), an inhibitory modification usually catalyzed by the PAK-effector LIMKs
(Yang et al., 1998; Figure 2F). In contrast, neither of these manipulations noticeably affected
rMLC phosphorylation on serine 19, which is catalyzed by another PAK-effector, MLCK
(Figure 2F). Hence, between the two effector pathways of PAKs (Figure 2A), the LIMK/
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cofilin pathway, but not the MLCK/rMLC pathway, was controlled by the ILK/β-parvin/
βPIX/Cdc42/PAK signaling in these cells.
Consistent with this notion, FLP formation in the MoT-cultured D2A1 cells was impaired by
overexpression of a constitutively active cofilin1 mutant (cofilin1 S3A; Moriyama et al.,
1996; Figure 3A). Moreover, the overexpression of either β-parvin or the constitutively
active mutant of either PAK1 or LIMK1 (PAK1 L107F and LIMK1-Kd3, respectively)
enabled the nonaggressive D2.1 cells to extend far more FLPs (2.4–2.7-fold increase in FLP
number), while failing to do so when the constitutively-active cofilin1 S3A mutant was
expressed concomitantly (Figure 3C). Collectively, these observations indicated that ILK/β-
parvin/βPIX/Cdc42/PAK signaling contributes to the display of abundant FLPs largely, if
not entirely, by causing LIMK-dependent cofilin inactivation, which protects the actin spine
of FLPs from cofilin-mediated cleavage, thereby resulting in the increased persistence of
FLPs (Figure 3B).
Two signaling pathways that cooperatively govern FLP formation
The ILK/β-parvin/βPIX/Cdc42/PAK/LIMK/cofilin (hereafter referred to as ‘ILK/β-parvin/
cofilin’) signaling axis characterized above was not the only determinant of FLP abundance.
In earlier work, we had uncovered the essential contribution of the Rif/mDia2 actin-
nucleating/polymerizing machinery to FLP formation (Shibue et al., 2012). Indeed, others
had shown that Rif and mDia2 cooperatively induce the nucleation of actin monomers and
subsequent elongation of actin filaments (Mellor, 2010), which comprise the structural core
of FLPs. These earlier observations, together with the presently demonstrated contribution
of cofilin-inactivating signaling pathway to FLP abundance, suggested that there are actually
two distinct signaling pathways – Rif/mDia2 signaling on the one hand and ILK/β-parvin/
cofilin signaling on the other – that collaborate in the induction and/ maintenance of FLPs
(Figure 3B). Thus, the first pathway causes the formation of actin fibers that drives the
initial extension of FLPs, while the second pathway ensures the stabilization of these FLPs
once they are formed.
We undertook to study in detail the cooperative actions of these two signaling axes. We
found that changes in FLP abundance induced by the enforced activation of Rif/mDia2
signaling were not associated with noticeable alterations in the cofilin1 phosphorylation on
S3, the site critical to the regulation of cofilin1 activity (Figures 2F, 3C). This contrasted
sharply with the regulation of FLPs by ILK/β-parvin/cofilin signaling, which involved and
depended critically on changes in cofilin activity (Figures 2F, 3C). Together, these
observations indicated the independent, complementary actions of these two signaling
pathways in regulating FLP abundance (Figure 3B).
We also analyzed the effect of simultaneously manipulating both pathways. Here we found
that the enhanced display of FLPs in the naturally poorly-FLP-forming D2.1 cells, which
could be achieved by the enforced activation of ILK/β-parvin/cofilin signaling, was reversed
by the concomitant knockdown of either Rif or mDia2 expression (Figure 3D). This
indicated that the tonic activity of Rif/mDia2 signaling is naturally maintained in the D2.1
cells and suggested that the inability of these cells to display abundant FLPs could be
ascribed largely to their ineffective activation of ILK/β-parvin/cofilin signaling, which
resulted in turn from their failure to synthesize significant levels of β-parvin protein (Figure
1C).
We proceeded further to examine the kinetics of FLP assembly and disassembly by time-
lapse imaging. Consistent with the effects of β-parvin in extending the lifetime of FLPs
(Figures 1E, S1G), inhibition of ILK/β-parvin/cofilin signaling in the aggressive D2A1 cells,
achieved by the expression of either dominant-negative PAK1-AID fragment or
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constitutively active cofilin1 S3A mutant, reduced the persistence period of FLPs, while the
enforced activation of this signaling in the indolent D2.1 cells increased this persistence
(Figures 3E, 3F). However, none of these manipulations noticeably affected the rate of de
novo FLP formation. In contrast, the enforced elevation of Rif/mDia2 signaling activity in
the indolent D2.1 cells resulted in a significant (≥ 1.9-fold) increase in the rate of FLP
initiation and a modest extension of FLP lifetime (Figure 3F, Movies S6, S8).
These observations reinforced the notion that Rif/mDia2 signaling contributes primarily to
the de novo formation of FLPs by stimulating the nucleation/polymerization of the actin
fibers that structurally support FLPs, while ILK/β-parvin/cofilin signaling specifically helps
to maintain the resulting FLPs by suppressing the cofilin-dependent cleavage of such actin
fibers. Together, these two signaling collaborate to enable cells to display large numbers of
FLPs (see Figure 3B).
ILK/β-parvin/cofilin signaling and in vitro cell behavior
As mentioned above, we had found that the formation of FLPs contributes to the assembly
of integrin β1-containing, mature adhesion plaques of elongated morphology in cells grown
in MoT culture, doing so by fostering the nucleation of protein complexes that comprise the
core of these plaques (Figure 4A; Shibue et al., 2012). Consistent with this earlier
observation, the inhibition of ILK/β-parvin/cofilin signaling – the signaling axis critical to
the extended lifetime and thus to the display of abundant FLPs – reduced the number of
integrin β1-containing adhesion plaques in the D2A1 cells growing in MoT culture (Figures
4B, S4A). In addition, the inhibition of ILK/β-parvin/cofilin signaling reduced the levels of
activation-associated phosphorylation of FAK and ERKs and attenuated proliferation when
the D2A1 cells were growing under MoT culture conditions, while not noticeably affecting
their proliferation in monolayer culture (Figures 4C–E, S4B–D). This reinforced the role of
FLP formation as a critical trigger for the establishment of cell-matrix adhesions and rapid
cell proliferation in cells grown in MoT culture (see Figure 4A).
We proceeded to test whether the contribution of ILK/β-parvin/cofilin signaling to these
processes was generalizable to other cancer cell types. In fact, our previous work had
demonstrated that, among 18 different lines of human breast cancer cells, those that were
competent to form metastatic colonies developed far more abundant FLPs than did their
colonization-deficient counterparts (Shibue et al., 2012). The subsequently pursued time-
lapse observations of such cells growing in MoT culture revealed that the FLPs formed in
the colonization-competent BT549, MDA-MB-231 and SUM1315 cells persisted far longer
than those extended by the colonization-deficient BT474, SK-BR-3, T47D and ZR-75-1
cells (Figure 1F). Consistently, these three colonization-competent cell types exhibited
elevated activity of the FLP-stabilizing ILK/β-parvin/cofilin signaling, as determined by
examining the levels of cofilin1 phosphorylation on S3 – the endpoint of this signaling
pathway (see Figure 3B), relative to the four colonization-deficient cell types tested here
(Figures S2E, S2F). Together, these observations supported the notion that the display of
abundant FLPs, observed specifically in the colonization-competent cells, is attributable, in
part, to the elevated activity of the ILK/β-parvin/cofilin signaling and the resulting
prolonged lifetime of FLPs.
We also blocked the activity of ILK/β-parvin/cofilin signaling in the colonization-competent
SUM159 and MDA-MB-231 human breast cancer cells. This resulted in impaired FLP
formation and reduced proliferation rate in MoT cultures, while minimally affecting their
proliferation in monolayer (2D) cultures (Figures S3A, 4F). Hence, ILK/β-parvin/cofilin
signaling contributed critically to the abundant FLP display and rapid cell proliferation in
the 3D MoT cultures of multiple colonization-competent carcinoma cell types.
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ILK/β-parvin/cofilin signaling and metastatic aggressiveness in vivo
The MoT culture used in the experiments cited above was designed to approximate the
microenvironment surrounding cancer cells that have recently extravasated into the lung
parenchyma (Barkan et al., 2008; Shibue and Weinberg, 2009). We wished to extend the
findings of these experiments by determining whether the ILK/β-parvin/cofilin signaling
axis also regulates metastatic cell behaviors in the lungs. In fact, various strategies to block
this signaling pathway all reduced (by 2.3- to 9.0-fold) the number of macroscopic lung
metastases formed 24 days after the tail-vein injection of the D2A1 cells; this was associated
with impaired proliferation within the lung tissue as measured 7 days after the injection
(Figures 5A, S5A). In contrast, none of these manipulations noticeably affected D2A1 cell
proliferation in monolayer culture (Figure 4C).
We also examined in detail lung sections prepared 10 days after tail-vein injection of the
D2A1 cells. Here again, the inhibition of ILK/β-parvin/cofilin signaling in the D2A1 cells
decreased (2.3- to 4.1-fold) the numbers of large metastatic colonies (those with > 20 cells/
colony), while the numbers of small colonies (≤ 20 cells/colony), which consisted largely of
viable but nonproliferative cells, were actually increased (1.3- to 2.4-fold; Figures 5B, S5B).
This echoed the previously-observed effect of knocking down Rif or mDia2 expression in
the D2A1 cells (Shibue et al., 2012). Together, these observations led us to conclude that
blocking FLP formation in the recently extravasated D2A1 cells constrains these cells to
reside in the lung parenchyma as viable, weakly-proliferating micrometastatic cells.
We undertook to analyze how the inhibition of ILK/β-parvin/cofilin signaling affects the
initial steps of extravasation and post-extravasation processes of metastasis. In fact, the
blockade of this signaling axis in the aggressive D2A1 cells did not noticeably affect the
efficiency of extravasation into the lung parenchyma, while being effective in reducing the
abundance of FLPs and mature adhesion plaques formed by the extravasated cells; this was
accompanied by a reduced level of FAK activation relative to that of the control cells
(Figures 5C, 5D, S5C–E). Hence, the action of ILK/β-parvin/cofilin signaling was critical,
following extravasation into the lung parenchyma, to the FLP-dependent establishment of
productive cell-matrix interactions by the D2A1 cells, which in turn governed their
subsequent proliferation (see Figure 4A).
We asked whether other types of colonization-competent cells also depend on the activity of
ILK/β-parvin/cofilin signaling in order to colonize the lung tissue. Accordingly, we tested
three colonization-competent mouse cell types, namely, TS/A mammary carcinoma cells,
B16F10 melanoma cells and TRAMP-C2 prostate cancer cells, all of which exhibited β-
parvin-dependent FLP formation in MoT culture (Figures 1G, S1I). We found that, in all
three cases, the knockdown of β-parvin expression reduced the number of macroscopic lung
metastases formed after tail-vein injection (Figures 5E, S5F). Similarly, blockade of ILK/β-
parvin/cofilin signaling in the human breast cancer cell lines SUM159 and MDA-MB-231
also impaired formation of lung macrometastases by these cells (Figure 5F). Notably, none
of these manipulations discernibly affected the proliferation of these cells in monolayer
cultures (Figures 4F, S4E). These observations confirmed the role of ILK/β-parvin/cofilin
signaling as a critical controller of metastatic aggressiveness in multiple cancer cell types.
FLP formation and tumorigenicity of orthotopically-implanted cells
These various observations caused us to test the involvement of ILK/β-parvin/cofilin
signaling in earlier steps of experimental tumor formation. Thus, we speculated that the
adaptations that experimentally implanted cancer cells must initially undergo in sites of
engraftment resemble those that are required for the establishment of disseminated cancer
cells as founders in sites of metastatic colonization. Based on this thinking, we implanted
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various cancer cell types into either orthotopic (mammary fat pads in the case of mammary
carcinomas) or ectopic subcutaneous sites in murine hosts, doing so with or without
manipulating these cells by blocking ILK/β-parvin/cofilin signaling. This revealed that some
of these manipulations reduced the incidence of primary tumor formation: for example, the
knockdown of βPIX expression reduced tumor incidence following the implantation of the
D2A1 cells in the mammary fat pad from 96% to 42–64% (Figure S6AC). This echoed our
previous observation that inhibition of Rif/mDia2 signaling in the D2A1 cells reduced the
rate of primary tumor formation after the orthotopic implantation (Shibue et al., 2012).
Together, these observations suggested that the ability of cells to display abundant FLPs
contributes to the establishment of primary tumors at sites of implantation.
We pursued these effects further by measuring tumor-initiating frequency of two cancer cell
types, namely D2A1 and MDA-MB-231 cells, after implanting them at limiting dilutions.
We found that blocking FLP formation, achieved by inhibiting either the Rif/mDia2 or ILK/
β-parvin/cofilin pathway, significantly reduced the estimated frequency of tumor-initiating
cells (TICs) in both cell populations (Figures 6A, S6D). This led us speculate that the
formation of FLPs, which enables rapid proliferation of cancer cells following extravasation
into the lung parenchyma (see Figure 4A), also governs the initial proliferation of cancer
cells at sites of implantation, thereby critically affecting the efficiency with which these cells
establish primary tumors in host mice.
Indeed, shortly after implantation into mammary fat pads, the D2A1 cells displayed FLPs,
which resembled those formed by these cells following extravasation into the lung
parenchyma (Figures 6B, 6C). Moreover, the number of FLPs formed 2 days after the
implantation of the D2A1 cells was decreased by blocking either the Rif/mDia2 or ILK/β-
parvin/cofilin signaling pathway, which was accompanied by the significant reduction of the
proliferation rate that was measured 3 days later (Figures 6D, 6E). Hence, the cooperative
actions of Rif/mDia2 and ILK/β-parvin/cofilin signaling pathways and the resulting,
abundant formation of FLPs (see Figure 3B) contributed critically to the active proliferation
of recently implanted D2A1 cells within mammary fat pads.
We also found that both Rif- and β-parvin-knockdown impaired FAK activation in the
orthotopically implanted D2A1 cells (Figure 6F). This attenuation of FAK signaling was
likely to account for the reduced TIC frequency caused by these knockdowns, since the
concomitant expression of the constitutively-active CD2-FAK fusion protein partially
restored this frequency (Figure 6G). In addition, the knockdown of FAK expression
impaired ERK activation in the mammary fat pad-implanted D2A1 cells (Figure 6F).
Together, these observations indicated that the proliferation of the recently implanted cancer
cells in the mammary fat pads is governed, in part, by the mechanisms involving FLP
extension and the resulting activation of FAK/ERK signaling, which mirrored the regulation
on the proliferation of recently extravasated cancer cells in the lungs (see Figure 4A).
Correlation between ILK/β-parvin/cofilin signaling activity and tumorigenic potential
We examined in greater detail the behavior of the D2A1 cells that had been recently
implanted into the mammary fat pads. This revealed that the numbers of FLPs formed by the
individual cells within the D2A1 cell population was highly variable from one cell to
another (Figure S6E), which led us to speculate that the cells displaying more abundant
FLPs had a higher tumor-initiating potential, i.e., an ability to seed tumors in host mice
following implantation, than did those forming only small numbers of these protrusions. To
test this, we fractionated the D2A1 cells into different subpopulations in order to examine
whether the FLP-forming ability of the cells in these various subpopulations correlated with
their content of TICs.
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Others have separated mouse mammary carcinoma cells based on the expression of CD29
and CD24 cell surface markers and found that the subpopulation of cells with CD29high/
CD24high (29H/24H) profile exhibited a significant enrichment of TICs (Zhang et al., 2008).
Consistent with this observation, we noted that the 29H/24H fraction of the D2A1 cells
exhibited a 4.1- and 27-fold higher TIC frequency than did the CD29high/CD24low (29H/
24L) and CD29low (29L) groups, respectively (Figures 7A, 7B). We also found that cells of
the aggressive 29H/24H subpopulation extended a larger number of FLPs than did the cells
of the other two subpopulations both in MoT culture and within the mammary fat pads
(Figures 7C, 7D, S7A). Hence, the observed difference in the TIC frequency of these
various D2A1 cell subpopulations correlated with the FLP-forming abilities of their
constituent cells.
Wishing to extend these observations to other cell types, we studied the HMLER
transformed human mammary epithelial cells (Elenbaas et al., 2001). As reported
previously, these HMLER cells can be sorted, according to the expression profile of the
CD44 and CD24 markers, into two subpopulations: a TIC-enriched CD44high/CD24low
(44H/24L) subpopulation and a TIC-depleted CD44low/CD24high (44L/24H) subpopulation
(Mani et al., 2008; Figure 7E). When propagated in MoT culture, cells of the 44H/24L
subpopulation displayed a far larger (13.4×) number of FLPs than did cells of the 44L/24H
subpopulation (Figure 7F). Hence, in both the D2A1 and HMLER cultures, the cells from
the TIC-enriched subpopulations extended FLPs more abundantly than did the cells from the
TIC-depleted subpopulations.
We undertook to identify the determinants of differing FLP abundance between the cells of
these various subpopulations. Time-lapse observation of these cells growing in the MoT
culture revealed that FLPs formed by cells of the TIC-enriched subpopulations (i.e., 29H/
24H in the D2A1 cells and 44H/24L in the HMLER cells) exhibited significantly longer
lifetime than those extending from cells of the corresponding other subpopulations (Figures
S7C, S7D). Consistent with this observation, cells of these TIC-enriched subpopulations
exhibited a higher level of the cofilin1-inactivating S3 phosphorylation – the endpoint of the
signaling pathway that governs FLP lifetime, i.e., ILK/β-parvin/cofilin signaling (see Figure
3B) – than did the cells of the other subpopulations (Figure 7G). Moreover, FLP formation
by cells of the HMLER 44H/24L subpopulation was impaired by expressing the
constitutively active cofilin1 S3A mutant in these cells, which ultimately reduced the TIC
frequency in this subpopulation (Figures 7H, S7E, S7F). Collectively, these various
observations supported the notion that the elevated TIC frequency – observed in the 29H/
24H subpopulation of the D2A1 cells and the 44H/24L subpopulation of the HMLER cells –
is attributable, in part, to the enhanced FLP-stabilizing ability of their constituent cells,
which results, in turn, from the elevated activity in these cells of the ILK/β-parvin/cofilin
signaling.
ILK/β-parvin/cofilin signaling and the process of epithelial-mesenchymal transition
Cancer cells can often develop a higher tumor-initiating potential during the course of tumor
progression (Pece et al., 2010). In the case of carcinomas, this acquisition of malignant
phenotypes is often achieved by the passage through the cell-biological program termed the
epithelial-mesenchymal transition (EMT); moreover, as demonstrated previously, the forced
induction of an EMT in cancer cells endows them with a greatly increased tumor-initiating
potential (Mani et al., 2008; Morel et al., 2008).
These earlier observations, together with our present demonstration of the critical role of
FLPs in the process of tumor initiation, prompted us to ask whether the EMT-dependent
induction of the tumor-initiating potential involves and depends on the enhancement of FLP
formation. Accordingly, we ectopically expressed the Twist transcription factor, an inducer
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of the EMT program (Yang et al., 2004), in the naturally-epithelial HMLER cells (Figures
8A, 8B, S8A). Consistent with previous observations (Mani et al., 2008), Twist-induced
EMT in these cells was accompanied by an enhanced tumor-initiating potential in the
mammary fat pads (132-fold increase in TIC frequency) and an increased power of
metastasis formation (Figures 8C, 8D).
Of relevance here, Twist-induced EMT in the HMLER cells stimulated their FLP-forming
ability both in MoT culture and following orthotopic implantation, which was accompanied
by marked increases in the expression levels of multiple components of the ILK/β-parvin/
cofilin signaling, namely ILK (4.7×), β-parvin (13.6×) and LIMK1 (3.2×) (Figures 8B, 8E,
8F). Moreover, both the elevated expression of these three components of the ILK/β-parvin/
cofilin signaling pathway and the enhanced display of FLPs were reproduced by other
strategies of EMT induction, specifically the overexpression of Snail transcription factor and
the knockdown of E-cadherin adhesion protein (Figures 8B, 8E).
We proceeded to examine the functional role of the elevated β-parvin expression on the
behavior of Twist-expressing HMLER cells. This revealed that the knockdown of β-parvin
expression partially reversed multiple properties conferred on these cells by the expression
of Twist, including increased FLP abundance and elevated phosphorylation levels of PAK1
(on T423 and S199/204) and cofilin1 (on S3), all of which were observed in MoT culture
(Figures 8B, 8E, 8F, S8B). Moreover, β-parvin knockdown also reduced the aggressiveness
of HMLER-Twist cells in vivo: both tumor initiation and metastasis formation were
impaired significantly by this knockdown (Figures 8C, 8D). We concluded that the elevated
tumor-initiating and metastasis-forming powers imparted to the HMLER cells by Twist-
induced EMT, and presumably by the EMTs induced by other strategies, depended on
enhanced FLP display; this was enabled, in turn, by the elevated expression levels of several
components of ILK/β-parvin/cofilin signaling pathway including β-parvin.
We also tested whether the connection between FLP formation and EMT process could be
extended to other cell types. Accordingly, we induced an MET (mesenchymal-epithelial
transition) – the reverse process of EMT – in the naturally mesenchymal D2A1 cells, doing
so by the combination of Snail knockdown and E-cadherin overexpression (Figures 8B,
S8C–F). As anticipated, the D2A1 cells that underwent an MET exhibited a profound loss of
tumor-initiating and metastasis-forming powers (Figures 8C, 8D). Moreover, this MET
induction was associated with the 2.7-fold decrease in the number of FLPs formed by these
cells in MoT culture (Figure S8G). In addition, the D2A1 cells that underwent an MET also
exhibited decreased expression of several components of the ILK/β-parvin/cofilin signaling
pathway, namely, ILK, β-parvin and LIMK1, all of which contrasted to the effects of EMT
in the HMLER cells (Figures 8B, S8H). Hence, in both HMLER cells and the D2A1 cells,
the transition between the epithelial and mesenchymal states involved changes in the
expression levels of multiple components of the ILK/β-parvin/cofilin signaling pathway.
This altered, in turn, their ability to form FLPs and ultimately contributed to changes in
tumor-initiating and metastasis-forming powers exhibited by the cells undergoing this cell
state transition.
Discussion
While the role of integrin-mediated cell-matrix adhesions in enabling the outgrowth of
metastases had been recognized (Aguirre Ghiso et al., 1999; Barkan et al., 2008), the manner
by which extravasated cancer cells interact with the ECM components of the parenchyma of
their host tissue remained to be elucidated. We previously reported that the ability of cancer
cells to form abundant FLPs following extravasation into the parenchyma of foreign tissues
contributes critically to the establishment by these cells of productive interactions with the
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ECM of their host tissue (Shibue et al., 2012). We also demonstrated the essential role of
Rif/mDia2 actin-nucleating/polymerizing machinery in the formation of FLPs. Here we have
described two findings that together provide an important extension to our understanding of
the role of FLPs in controlling cancer cell behaviors.
To begin, we identified a signaling mechanism that yields an extended lifetime of FLPs and
thereby contributes to the abundance of these protrusions in the colonizationcompetent
cancer cells. Thus, the activation of the ILK/β-parvin/cofilin signaling axis at sites of FLP
formation enables the persistence of these protrusions once they are assembled. As is the
case with the Rif/mDia2 signaling (Shibue et al., 2012), the action of ILK/β-parvin/cofilin
signaling is critical to the metastatic colony-forming ability of multiple aggressive cancer
cell types.
Importantly, the enforced activation of this signaling pathway, on its own, does not always
suffice to confer metastatic powers on otherwise-indolent cancer cells. For example, in the
nonaggressive D2.1 cells, which do not express β-parvin at a detectable level, ectopic β-
parvin expression sufficed to enable these cells to display abundant FLPs in MoT culture.
However, these β-parvin-expressing D2.1 cells did not subsequently succeed in developing
mature adhesion plaques and in proliferating rapidly under the MoT conditions, nor did they
form a large number of macroscopic metastases in the lungs following tailvein injection
(Figure S3). Hence, these D2.1 cells appeared to suffer one or more additional defect(s)
beyond the lack of β-parvin expression that precluded their aggressive behavior both in MoT
culture in vitro and within the lung parenchyma in vivo.
While not addressed directly by the present work, we suggest that the dynamics of FLP
formation and the contribution of FLPs to metastatic outgrowth will prove to be relevant to
the colonization process of various target tissues. Indeed, we previously demonstrated that
blocking FLP formation by Rif knockdown in the B16F10 melanoma cells diminishes the
ability of these cells to colonize multiple organs, such as the lungs, liver and bone marrow,
following intracardiac injection into syngeneic mice (Shibue et al., 2012). This prompts us
to suggest that FLP formation and resulting establishment of productive cell-matrix
interactions represent a common prerequisite to the metastatic colonization of many types of
target organs.
The second lesson of the present study relates to the role of FLPs in the establishment of
primary tumors by experimentally implanted cancer cells. Thus, as shown here, multiple
cancer cell types depend on the FLP-regulating signaling pathways for efficiently
establishing primary tumors following experimental implantation in murine hosts. In support
of this finding, we also presented examples where the increased tumor-initiating potential of
cancer cells was correlated closely with their enhanced ability of FLP formation. More
specifically, cells of the TIC-enriched subpopulations of both D2A1 and HMLER cells
displayed FLPs far more abundantly than the remaining cells in these populations.
Recent studies have revealed that many types of solid tumors contain both cells that can
efficiently seed tumors upon transplantation into mice and those that are unable to do so;
these are often referred to as cancer stem cells (CSCs) and non-stem cancer cells (non-
CSCs), respectively (Clevers, 2011). The efficient tumor seeding by many, if not all, types
of carcinoma CSCs is likely to be supported by the EMT program. Indeed, the induction of
EMT suffices to confer on cancer cells not only an increased tumor-initiating potential but
also many other attributes of CSCs, including enhanced resistance to chemotherapeutic
agents and a slower rate of proliferation (Gupta et al., 2009). However, the specific
mechanism(s) by which the EMT program potentiates the tumor-initiating powers of
carcinoma cells has remained elusive. The present observations point to the contribution of
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the EMT program to increasing the expression of proteins that are critical for FLP
formation, and to the role of FLP formation in governing tumor-initiating potential.
Together, this provides a mechanistic explanation of how the EMT program can contribute
to the elevated tumor-initiating ability of CSCs.
To summarize, we propose that in certain and perhaps many types of cancer cells, their
initial proliferation following both experimental implantation and metastatic dissemination
is governed, in part, by the common regulatory mechanism involving FLP formation and the
resulting assembly of mature adhesion plaques. Clearly, other factors, such as cytokines,
growth factors, and responsive stromal cells in the microenvironment, must also contribute
to determining the eventual successful formation of both primary and metastatic tumors.
Nonetheless, the initial formation of FLPs, which depends critically on the Rif/mDia2 and
ILK/β-parvin/cofilin signaling pathways, appears to constitute a key rate-limiting step that
governs both processes of tumor formation.
Experimental Procedures
Cell culture
The Matrigel on-top (MoT) culture was performed as described previously (Shibue and
Weinberg, 2009). Unless otherwise indicated, cells were propagated for 12 hours (for FLP
formation), 5 days (for adhesion and phosphorylation analyses) or 10 days (for cell number
determination).
Animal procedure
All animal experiments conformed to the Guide for the Care and Use of Laboratory Animals
published by the National Research Council and were approved by the MIT Committee on
Animal Care.
Live-cell imaging
Live-cell imaging was performed on a spinning-disc confocal microscopy system, equipped
with a Nikon Eclipse TE2000E inverted microscope.
Statistical analysis
Statistical analyses were carried out by Student’s t-test, unless otherwise indicated.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Abundance of filopodium-like protrusions (FLPs) depends on their persistence
periods.
• Integrin-actin linking proteins govern cofilin activity as well as FLP persistence.
• FLPs critically support both metastatic outgrowth and experimental tumor
formation.
• Epithelial-mesenchymal transition (EMT) in carcinoma cells enhances FLP
formation.
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Significance
The proliferation of recently extravasated metastatic cancer cells and experimentally
implanted cancer cells depends on their ability to establish integrin-mediated adhesions
with the extracellular matrix of the tissues that they initially encounter. The formation of
these adhesions is enabled by the extension of filopodium-like protrusions (FLPs), whose
formation, in turn, is encouraged by the epithelial-mesenchymal transition (EMT)
program. In this fashion, the EMT program facilitates proliferation of both recently
extravasated metastatic carcinoma cells and those that are experimentally implanted.
These dynamics help to explain how the EMT program can increase the tumor-initiating
potential of carcinoma cells – the trait that is used experimentally to define cancer stem
cells.
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Figure 1. β-parvin as a key regulator of FLP formation
(A) Kinetics of FLP assembly and disassembly. Three different D2 cell populations
(expressing an actin marker lifeact-YPet) were analyzed by time-lapse microscopy. The
appearance of new FLPs and the retraction of previously-present FLPs are marked by blue
and open-white arrowheads, respectively. The periods of FLP persistence (top-left) and the
rate of de novo FLP formation (bottom-left) were plotted. See also Movies S1–S3.
(B, C) mRNA (B) and protein (C) expression for various integrin:actin-linkers.
(D) Role of ILK/β-parvin in FLP formation. D2A1 cells with knockdowns for various
integrin:actin-linkers or overexpression of α-parvin were propagated in MoT cultures and
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stained with phalloidin (F-actin; green) and DAPI (nuclei; blue) (right). The numbers of
FLPs per cell were plotted (left). Knocking down the expression of β-parvin and ILK, but
not the overexpression of α-parvin, reduced FLP abundance. Hence, the expression level of
β-parvin, but not that of α-parvin, has a critical effect on FLP abundance.
(E) Contribution of β-parvin to the extended FLP lifetime. The D2A1 cells manipulated as
indicated (also expressing lifeact-YPet) were analyzed as in A. See also Movies S4, S5.
(F) Persistence of FLPs formed by human breast cancer cells. Various human breast cancer
cell lines (expressing lifeact-YPet) were analyzed by time-lapse microscopy for FLP
persistence and the rate of de novo FLP formation.
(G) β-parvin-dependent FLP formation in various metastatic cell types. Three metastatic
mouse cell types were analyzed for FLP formation in MoT cultures.
Values = means ± SD (n = 3: B) or means ± SEM (n ≒ 20: A, E, F; n = 100: D, G). Bars =
10 µm. In A and E, (*) p < 0.002 (by log-rank test; vs D2A1 in A, vs sh scrambled in E),
(ns) p > 0.1. In D and G, (*) p < 0.01 (vs sh scrambled/mock), (ns) p > 0.3. See also Figure
S1.
Shibue et al. Page 18
Cancer Cell. Author manuscript; available in PMC 2014 October 14.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2. ILK/β-parvin/βPIX/Cdc42/PAK/LIMK/cofilin signaling in FLP formation
(A) Integrin-actin coupling by ILK/α-parvin and ILK/β-parvin complexes. α-parvin and β-
parvin bind to ILK, each providing a link between integrins and actin cytoskeleton, while
having different effects on cell behaviors.
(B) β-parvin/βPIX interactions. Lysates from FLAG-β-parvin-, FLAG-α-parvin- or FLAG-
βPIX-expressing cells were subjected to anti-FLAG immunoprecipitation and analyzed by
immunoblotting. βPIX interacts with β-parvin, but not with α-parvin. (*) nonspecific bands.
(C) Role of βPIX in FLP regulation. Knocking down the expression of βPIX, but not that of
dysferlin (a transmembrane protein that interacts with β-parvin; Matsuda et al., 2005)
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reduced FLP abundance in the D2A1 cells. Values = means ± SEM (n = 100). (*) p < 0.001,
(ns) p > 0.3.
(D) β-parvin expression and Cdc42 activation. Values represent the intensities of the active
Cdc42 bands relative to that of corresponding total Cdc42 band.
(E) β-parvin/Cdc42/βPIX signaling in PAK phosphorylation. Here and in F, values represent
the intensities of pPAK1 (phospho-cofilin1/phospho-rMLC) bands relative to that of the
corresponding total PAK1 (cofilin1/rMLC) band. The blots are representative of multiple
independent experiments.
(F) Cofilin and rMLC phosphorylation in the downstream of β-parvin/PAK signaling. Bars
= 10 µm. See also Figure S2.
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Figure 3. Cooperation of Rif/mDia2 and ILK/β-parvin/cofilin pathways in FLP regulation
(A) Role of PAK/LIMK/cofilin axis in FLP regulation. Cells manipulated as indicated to
alter the activity of PAK/LIMK/cofilin signaling were analyzed for FLP formation in MoT
cultures. Bar = 10 µm.
(B) Cooperation of the two signaling axes, Rif/mDia2 and ILK/β-parvin/cofilin, for
abundant FLP display.
(C) Differential requirement for cofilin inactivation between Rif/mDia2 and ILK/β-parvin/
cofilin signaling pathways. The control (mock) and cofilin1 S3A-expressing D2.1 cells were
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further engineered to activate either of Rif/mDia2 or ILK/β-parvin/cofilin signaling
pathways and analyzed for FLP formation.
(D) Requirement for basal Rif/mDia2 activity in β-parvin/PAK-driven FLP formation. The
D2.1 cells with enforced activation of ILK/β-parvin/cofilin signaling were further
engineered to knockdown Rif or mDia2 expression (left), while those with enforced Rif/
mDia2 activation were additionally engineered to knockdown βPIX or to overexpress
PAK1-AID (right), before the FLP formation by these cells was analyzed.
(E, F) Effects of signaling manipulation on FLP dynamics. D2A1 (E) and D2.1 (F) cells
(expressing lifeact-YPet) were engineered to block and stimulate FLP formation,
respectively, and analyzed by time-lapse microscopy. See also Movies S6–S8.
Values = means ± SEM (n = 100: A, C, D; n ≒ 20: E, F). (*) p < 0.0001, (**) p < 0.05, (ns)
p > 0.2 (by Student’s t-test). (***) p < 0.0001 (vs mock; by log-rank test). See also Figure
S3.
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Figure 4. in vitro effects of ILK/β-parvin/cofilin signaling manipulation
(A) Cell-biological and biochemical events that drive cell proliferation in MoT culture and
within the lung parenchyma.
(B, C) Role of ILK/β-parvin/cofilin signaling in adhesion plaque assembly and proliferation.
The D2A1 cells were manipulated as indicated, with which the rate of mature adhesion
plaque assembly in MoT culture (B) and the cell numbers after 10 days of monolayer or
MoT culture (C) were determined. Bar = 10 µm.
(D, E) β-parvin/PAK signaling and FAK/ERK activation. Values represent the intensities of
pFAK (pERK) bands relative to that of the corresponding total FAK (ERK) band.
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(F) ILK/β-parvin/cofilin signaling and proliferation in various cell types. Indicated cell types
were manipulated to block ILK/β-parvin/cofilin signaling, with which the cell numbers after
10 (15 for MDA-MB-231) days of monolayer/MoT cultures were determined.
Values = means ± SD (n = 3: B, C, F). (*) p < 0.02, (ns) p > 0.1 (vs sh scrambled/mock).
See also Figure S4.
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Figure 5. in vivo effects of ILK/β-parvin/cofilin signaling manipulation
(A, B) ILK/β-parvin/cofilin signaling and metastatic colonization. The D2A1 cells
expressing fluorescent markers (GFP or tdTomato; A, tdTomato-membrane; B) were
manipulated as indicated and tail-vein injected. In A, representative lung images (left) and
the numbers of macrometastases (right) 24 days after injection, as well as the phospho-
histone H3 positivity of the cells residing in the lungs 7 days after injection (middle), were
presented. Here and in E, F, the red bar represents the mean value within each sample group.
In B, relative numbers of small (≤ 20 cells) and large metastases (> 20 cells) were quantified
on the lung sections prepared 10 days after injection. M = large metastases.
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(C, D) β-parvin/PAK axis and in vivo cell-matrix adhesions. In C, the D2A1 cells expressing
integrin α5-YPet (green) and lifeact-Tag-RFP-T (red), further engineered as indicated, were
tail-vein injected. FLP formation was analyzed on the lung sections, where blood vessels
(PECAM-1; white) and nuclei (Hoechst 33342; blue) were also visualized (left/middle). The
formation of elongated adhesion plaques was scored similarly, except for using α-actinin-
Tag-RFP-T fusion protein instead of lifeact-Tag-RFP-T (right). In D, the D2A1 cells
engineered as indicated, also expressing FAK-HA, were tail-vein injected. 5 days later,
FAK-HA was immunoprecipitated from the lung lysate and analyzed by immunoblotting.
(E, F) Role of ILK/β-parvin/cofilin signaling in lung colonization by various cell types. The
control and manipulated B16F10, TRAMP-C2, SUM159 and MDA-MB-231 cells, also
expressing GFP (E) or tdTomato (F), were tail-vein injected and subsequent formation of
lung metastases was analyzed.
Values = means ± SD (n = 3: A [middle], B, C [right]); means ± SEM (n = 150: C [left]).
Bars = 2 mm (A, E, F), 100 µm (B), 10 µm (C). (*) p < 0.005, (**) p < 0.05, (ns) p > 0.05
(vs sh scrambled/mock). See also Figure S5.
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Figure 6. FLP formation and tumorigenesis of experimentally-implanted cells
(A) Role of FLP-regulating proteins in primary tumor formation. The D2A1 cells were
engineered as indicated and implanted into the mammary fat pads. 28 days later, the
formation of palpable tumors was scored, from which TIC frequency was calculated.
(B, C) FLPs and elongated adhesion plaques formed by the mammary fat pad-implanted
cells. The D2A1 cells expressing integrin α5-YPet (green) and either of the lifeact-Tag-RFP-
T (red; B) or α-actinin-Tag-RFP-T (red; C) were implanted, together with non-labeled
D2A1 cells. The formation of FLPs (blue arrowheads; B) and elongated adhesion plaques
(pink arrowheads; C) was analyzed on the sections of the fat pads.
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(D, E) Effect of blocking FLP formation in the mammary fat pad-implanted cells. In D,
fluorescent-labeled and non-labeled D2A1 cells, further manipulated as indicated, were
mixed and implanted to analyze FLP formation within the mammary fat pads. In E, D2A1
cells were engineered as indicated and implanted. Proliferation and apoptosis of implanted
cells were analyzed by staining the sections of the fat pads for Ki67 (red) and cleaved
caspase-3 (green), respectively.
(F) FAK/ERK activation in the mammary fat pad-implanted cells. The D2A1 cells
expressing either of FAK-HA or FLAG-ERK1 were further manipulated as indicated and
implanted. Subsequently, FAK-HA or FLAG-ERK1 was immunoprecipitated from the
lysate of the fat pads and analyzed.
(G) Restoring tumor-initiating ability by enforced FAK activation. The D2A1 cells with Rif
or β-parvin knockdown were further manipulated to express the constitutively active CD2-
FAK. Primary tumor formation by these and the control cells was analyzed. Bars = 10 µm
(B-D), 100 µm (E). (*) p < 0.01, (ns) p > 0.1. See also Figure S6.
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Figure 7. Display of abundant FLPs by cells of the TIC-enriched subpopulation
(A) Sorting of the D2A1 cells by CD29/CD24 expression. The cells of each subpopulation
were implanted into mammary fad pads to score primary tumor formation (right).
(B) Tumor sphere formation by the sorted D2A1 cells. Cells were sequentially passaged for
the 3 rounds of 10-day culture. The numbers of tumorspheres after each round of culture
were scored (bottom). Representative images of cells after the 2nd round of culture are also
presented (top).
(C, D) Formation of FLPs and elongated adhesion plaques by the sorted D2A1 cells. In C,
sorted D2A1 cells were propagated in MoT cultures to analyze FLP/elongated adhesion
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plaque formation. In D, the D2A1 cells that did and did not express the fluorescent actin
marker lifeact-YPet (green) were sorted, mixed and implanted. The formation of FLPs (gray
arrowheads) by these cells was analyzed on the sections of the fat pads.
(E) Sorting of the HMLER cells by CD44/CD24 expression.
(F) Formation of FLPs and elongated adhesion plaques by the sorted HMLER cells in MoT
cultures.
(G) Expression of FLP-regulating proteins in cells of the various D2A1 and HMLER
subpopulations. Cells of these subpopulations were propagated in MoT cultures and
analyzed by immunoblotting.
(H) Blocking ILK/β-parvin/cofilin signaling in the 44H/24L subpopulation of HMLER cells.
HMLER cells were manipulated to express constitutively active cofilin1 S3A. These and the
control cells were sorted and 44H/24L subpopulation obtained from each cell type was
implanted to score primary tumor formation.
Values = means ± SD (n = 3: B, C [right], F [right]); means ± SEM (n = 100: C [left], F
[left]). Bars = 200 µm (B), 10 µm (C, D, F). (*) p < 0.005, (**) p < 0.02. See also Figure S7.
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Figure 8. Functional connection between FLP formation and EMT program
(A) Twist-induced EMT in the HMLER cells. The control (mock) and Twist-expressing
HMLER cells were propagated as a monolayer and stained for E-cadherin (green),
fibronectin (red) and the nuclei (blue) (right). Differential interference contrast (DIC)
images of these cells are also presented (left).
(B) Changes in the expression levels of EMT-markers and FLP-regulators. HMLER cells
and D2A1 cells were engineered as indicated to undergo an EMT and MET, respectively.
These and the control cells were propagated either as a monolayer (left) or in MoT cultures
(right) and analyzed by immunoblotting.
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(C, D) Effect of EMT/MET on primary tumor formation and metastatic colonization. In C,
indicated cell types were mammary fat pad-implanted and primary tumor formation was
scored. In D, indicated cells types, also expressing GFP or tdTomato, were tail-vein injected
to score metastasis formation in the lungs. The numbers of macrometastases observed on the
surface of the entire lungs (HMLER) or left upper lobe of the lungs (D2A1) are presented.
(E, F) FLP formation before and after EMT induction. In E, the HMLER cells engineered as
indicated were analyzed for FLP formation in MoT culture. (*) p < 1 × 10−5. In F, HMLER
cells engineered as indicated were further manipulated to express lifeact-YPet. These and
non-labeled cells were mixed and fad pad-implanted to score the formation of FLPs (gray
arrowheads).
Values = means ± SEM (n ≥ 5: D, n = 100: E). Bars = 100 µm (A [left]), 20 µm (A [right]),
2 mm (D), 10 µm (E, F). See also Figure S8.
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